Jp 4502 News Today

By Kosaku Narioka Takeda Pharmaceutical is scheduled to report its third-quarter results on Thursday. Here is what you need to know: NET PROFIT FORECAST:...

Pharmaceutical company Takeda said Wednesday that the U.S. Food and Drug Administration approved Fruzaqla as a treatment for certain patients with colorectal...

By Paul Ziobro Shares of Neurocrine Biosciences fell in late trading after the biopharmaceutical company said that two studies failed to achieve desired...

By Kosaku Narioka Takeda Pharmaceutical shares fell sharply after it reported a second-quarter net loss due to impairments on certain products and cut its...

By Kosaku Narioka Takeda Pharmaceutical is scheduled to report second-quarter results on Thursday. Here is what you need to know: NET PROFIT FORECAST: Takeda...

Takeda said Tuesday its trial of darvadstrocel in the treatment of complex Crohn's Perianal Fistulas didn't meet its primary endpoint based on topline data.

American depositary receipts of Takeda Pharmaceutical Co. rose more than 1% in the extended session Tuesday after the Japan-based company said its dengue...

By Denny Jacob Takeda Pharmaceutical's vaccine to prevent dengue, qdenga, was recommended by a World Health Organization advisory group. The company, which...

By Denny Jacob Takeda Pharmaceutical plans to voluntarily withdraw exkivity following discussions with the Food and Drug Administration. The company, which...

By Kosaku Narioka Takeda Pharmaceutical said Thursday that its first-quarter net profit fell 15% from a year earlier despite revenue growth in several key...